• 1. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 2. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Introduction to Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate (CAS No. 1822467-21-9)

Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate (CAS No. 1822467-21-9) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its unique structural features, plays a crucial role in the synthesis and development of various therapeutic agents. Its molecular structure, featuring a piperidine ring substituted with hydroxyl and methoxy groups, as well as a tert-butyl ester moiety, makes it a versatile intermediate in organic synthesis.

The piperidine ring is a six-membered heterocyclic amine that is commonly found in many biologically active molecules. Its presence in Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate contributes to its potential pharmacological properties. The hydroxyl and methoxy functional groups attached to the piperidine ring further enhance its reactivity and utility in drug design. Specifically, the hydroxyl group can participate in hydrogen bonding interactions, while the methoxy group can serve as a lipophilic anchor, influencing the compound's solubility and bioavailability.

In recent years, there has been a growing interest in developing novel piperidine-based compounds for their applications in treating various diseases. Research has shown that piperidine derivatives exhibit a wide range of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The tert-butyl ester group in Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate not only enhances the stability of the molecule but also provides a site for further chemical modification, allowing for the creation of more complex and potent pharmacological agents.

One of the most compelling aspects of Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate is its role as a key intermediate in the synthesis of peptide mimetics. Peptide mimetics are designed to mimic the biological activity of natural peptides while avoiding their limitations, such as poor oral bioavailability and susceptibility to enzymatic degradation. The piperidine scaffold is particularly useful in this context because it can be modified to create structures that closely resemble natural peptide sequences while maintaining enhanced pharmacokinetic properties.

Recent studies have highlighted the importance of Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate in the development of small molecule inhibitors for targeted therapy. For instance, researchers have utilized this compound to synthesize inhibitors targeting specific enzymes involved in cancer progression. The ability to modify the piperidine ring with various substituents allows for fine-tuning of the inhibitory activity, making it possible to develop highly selective and effective drugs.

The synthesis of Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include nucleophilic substitution reactions, esterifications, and cyclizations. Advanced techniques such as palladium-catalyzed cross-coupling reactions have also been employed to introduce specific functional groups into the molecule with high efficiency.

The chemical properties of Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate make it an attractive candidate for further exploration in drug discovery. Its solubility profile, stability under various conditions, and reactivity towards further functionalization are all favorable attributes for developing new therapeutic agents. Moreover, its structural features align well with current trends in medicinal chemistry towards designing molecules with improved pharmacological profiles.

In conclusion, Tert-butyl 4-hydroxy-3-methoxypiperidine-1-carboxylate (CAS No. 1822467-21-9) is a compound of significant interest in pharmaceutical research due to its unique structural features and potential applications in drug development. Its role as an intermediate in synthesizing peptide mimetics and enzyme inhibitors underscores its importance in advancing therapeutic strategies for various diseases. As research continues to uncover new applications for this compound, it is likely to remain a valuable tool for chemists and medicinal chemists working on next-generation pharmaceuticals.

• 1638760-09-4(tert-butyl trans-3,4-dihydroxypiperidine-1-carboxylate)
• 951766-53-3(1-Piperidinecarboxylic acid, 3,4-dihydroxy-, 1,1-diMethylethyl ester, (3R,4S)-)
• 1353980-11-6(Tert-butyl 3-(2-hydroxyethoxy)piperidine-1-carboxylate)
• 480450-33-7(tert-butyl cis-3,4-dihydroxypiperidine-1-carboxylate)
• 2382396-70-3(tert-butyl (3R,4R)-4-hydroxy-3-methoxy-piperidine-1-carboxylate)
• 475062-48-7
• 1352077-53-2(Tert-butyl 2-(1-hydroxypropyl)morpholine-4-carboxylate)
• 874461-87-7(2-Oxazolidinone, 5-[(1R)-1-hydroxyundecyl]-3-(3-methylbutyl)-, (5R)-rel-)
• 146337-23-7(Tert-butyl 3-methoxypiperidine-1-carboxylate)
• 109384-22-7(1-Piperidinecarboxylic acid, 3-[(aminocarbonyl)oxy]-, 1,1-dimethylethyl ester, (±)-)